Pharmacy Business

How a pharmacist's role in COVID-19 differs from province to province
The Canadian Foundation for Pharmacy has released an updated COVID-19 chart with new information on how provinces differ on if pharmacists give COVID-19 vaccines, can dispense and prescribe Paxlovid, and distribute RAT tests—and how much they're paid for those tasks.
$175M pharmaceutical distribution centre opens in Edmonton
The 300,000-square-foot pharmaceutical distribution centre is one of the largest in Canada.

Pharmacists must be on site to supervise, ACP reminds licencees

The Alberta College of Pharmacy has issued a reminder to pharmacists that they must be on site to supervise restricted activities.
Rumour has it: Doctor speaks out against pharmacy loyalty points

A rumour about people intentionally infecting themselves with Hep C made a Nova Scotia doctor speak out about the dangers of people collecting loyalty points on prescription drugs.
New guidance released on helping patients manage the specialty baby formula shortage

New guidance from the the College of Pharmacists of Manitoba includes a decision tree for pharmacists to help parents navigate their formula choices safely.
The number of Canadians without prescription drug coverage is dropping

More Canadians now have prescription drug coverage, with the number of uninsured Canadians decreasing from 5.2% in 2016 to 2.8% in 2020.
CVS Pharmacy pilots Skin Care Center

The Skin Care Center format, launched in three locations, features a wholly owned shop-in-shop experience that will provide shoppers with enhanced access to skin health innovations.
Pharmacists should provide more mental health services, says International Pharmaceutical Federation

Pharmacists could be a valuable addition to the mental-health workforce, says the federation.
How pharmacists can tackle climate change

Five tips you can use in your practice now.
Federal government invests $10 million in initiative to assess outpatient treatments for COVID-19

The federal government announced it will invest $10 million to research outpatients medications for COVID-19 through the Can-ADAPT COVID research platform.